Literature DB >> 15986183

[Early transfer from intensive care does not influence clinical results of carotid endarterectomy].

S Ockert1, D Böckler, H Schumacher, R Seelos, K Klemm, J-R Allenberg.   

Abstract

The purpose of this prospective observational study was to examine the necessity of intensive care after carotid endarterectomy (CEA). In consideration of the neurological stage and comorbidities, morbidity and mortality after early transfer from the intensive care unit (ICU) were examined. The CEA patients were assigned preoperatively to short or long monitoring. Those with symptomatic stenosis ranking > or =2 (stroke within 6 weeks before surgery) and ischemic areas in cCT were observed overnight (long) in the ICU. Within 5.5 months, 100 consecutive patients had received 107 CEAs. Preoperatively, seven of these (6.54%) were assigned to ICU overnight monitoring. 14 patients (13%) needed postoperative over night ICU. We observed no perioperative stroke or mortality in the 107 consecutive CEAs. We could not detect any risk factor in preoperatively determining the length of postoperative ICU monitoring. This prospective, single center study showed that, after CEA, it is safe to monitor patients for only a short period (4-8 h) in the ICU. Morbidity and mortality after early transfer to the regular ward did not increase.

Entities:  

Mesh:

Year:  2005        PMID: 15986183     DOI: 10.1007/s00104-005-1040-z

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  17 in total

1.  Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST)

Authors: 
Journal:  Lancet       Date:  1998-05-09       Impact factor: 79.321

2.  Immunophenotypic analysis of the aortic wall in Takayasu's arteritis: involvement of lymphocytes, dendritic cells and granulocytes in immuno-inflammatory reactions.

Authors:  S J Inder; Y V Bobryshev; S M Cherian; A Y Wang; R S Lord; K Masuda; C Yutani
Journal:  Cardiovasc Surg       Date:  2000-03

3.  The Carotid Surgery for Ischemic Stroke trial: a prospective observational study on carotid endarterectomy in the early period after ischemic stroke.

Authors:  H H Eckstein; P Ringleb; A Dörfler; K Klemm; B T Müller; M Zegelman; H Bardenheuer; W Hacke; T Bruckner; W Sandmann; J R Allenberg
Journal:  J Vasc Surg       Date:  2002-11       Impact factor: 4.268

4.  Feasibility and safety of 1-day postoperative hospitalization for carotid endarterectomy.

Authors:  J L Kaufman; D Frank; S W Rhee; J A Berman; P Friedmann
Journal:  Arch Surg       Date:  1996-07

5.  Selective use of the intensive care unit after nonaortic arterial surgery.

Authors:  S G Katz; R D Kohl
Journal:  J Vasc Surg       Date:  1996-08       Impact factor: 4.268

6.  Dollars and sense: the economics and outcomes of patients undergoing carotid endarterectomy at Royal Adelaide Hospital.

Authors:  Donna Hodby
Journal:  J Vasc Nurs       Date:  2002-03

7.  Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial.

Authors:  A Halliday; A Mansfield; J Marro; C Peto; R Peto; J Potter; D Thomas
Journal:  Lancet       Date:  2004-05-08       Impact factor: 79.321

8.  Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis.

Authors:  H J M Barnett; D W Taylor; R B Haynes; D L Sackett; S J Peerless; G G Ferguson; A J Fox; R N Rankin; V C Hachinski; D O Wiebers; M Eliasziw
Journal:  N Engl J Med       Date:  1991-08-15       Impact factor: 91.245

9.  Selective use of the intensive care unit following carotid endarterectomy.

Authors:  M D Morasch; D Hodgett; K Burke; W H Baker
Journal:  Ann Vasc Surg       Date:  1995-05       Impact factor: 1.466

10.  Same-evening discharge after carotid endarterectomy: our initial experience.

Authors:  Maureen K Sheehan; Howard P Greisler; Fred N Littooy; William H Baker
Journal:  J Vasc Surg       Date:  2004-03       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.